Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Leucegene: AML sequencing (part 6)

ABSTRACT: Leucegene: AML sequencing (part 6)

PROVIDER: PRJNA416098 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6230260_1.fastq.gz	Fastqsanger.gz
	SRR6230260_2.fastq.gz	Fastqsanger.gz
	SRR6230270_1.fastq.gz	Fastqsanger.gz
	SRR6230270_2.fastq.gz	Fastqsanger.gz
	SRR6230280_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 114

Similar Datasets

Homo sapiens

Project description:Leucegene: AML sequencing (part 4)

| PRJNA278364 | ENA

Homo sapiens

Project description:Leucegene: AML sequencing (part 5)

| PRJNA278767 | ENA

Homo sapiens

Project description:Leucegene: AML sequencing (part 3)

| PRJNA263397 | ENA

Homo sapiens

Project description:Leucegene: AML sequencing (part 1)

| PRJNA214592 | ENA

Homo sapiens

Project description:Leucegene: AML sequencing (part 2)

| PRJNA229548 | ENA

Leucegene: AML sequencing (part 2)

Project description:RNA sequencing of human leukemia The goals of this project are to obtain a comprehensive study of mutations and gene expression in human acute myeloid leukemia (AML). Methods: AML cells were thawed. DNA and RNA (polyA) was extracted and sequences were obtained with an illumina HiSeq 2000 sequencer. Results are pending.

2014-02-05 | E-GEOD-52656 | biostudies-arrayexpress

Leucegene: AML sequencing (part 4)

2015-07-09 | E-GEOD-66917 | biostudies-arrayexpress

Leucegene: AML sequencing (part 5)

2015-07-09 | E-GEOD-67039 | biostudies-arrayexpress

Leucegene: AML sequencing (part 3)

2015-07-09 | E-GEOD-62190 | biostudies-arrayexpress

The Leucegene AML surfaceome atlas: immunotherapeutic target identification in AML

Project description:We exploited the extensive genomic diversity of the Leucegene cohort of primary human AML specimens to provide an overview of the human AML surfaceome. Due to high cell number requirements, surface proteomics has been underexploited in AML so far, although surface proteome analysis of AML cell lines and small cohorts of primary human AML specimens paved the way for antigen identification23-25. Herein, we compared global and surface proteomic datasets generated from primary human AML specimens and show that surfaceome analysis uniquely identifies a larger subset of cell surface proteins compared to global proteomics. We therefore built a cohort of 100 primary human AML specimens that was subjected to surface proteome analysis and served as a primary dataset for antigen identification. A significant portion of the cohort also underwent single-cell RNA sequencing, which allowed the exploration of antigen expression at the population level and the selection of AML antigens expressed by primitive blasts. These analyses led to the identification of novel AML antigens expressed by the majority of AML specimens of the cohort, of antigens overexpressed by specific AML subgroups, as well as of previously uncovered potential leukemia stem cell (LSC) markers, and represents the first large-scale surface proteomic study in AML.

2024-05-21 | PXD044480 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data